Table 1 Correlation between GLO1high/nuc staining and patient characteristics
GLO1high/nuc | GLO1others | |||||
|---|---|---|---|---|---|---|
Features | Category | N | % | N | % | p value3 |
Age [years] | < 58.25 | 18 | 64.3 | 63 | 49.2 | 0.148 |
≥ 58.25 | 10 | 35.7 | 65 | 50.8 | ||
Gender | Male | 20 | 71.4 | 96 | 75.0 | 0.695 |
Female | 8 | 28.6 | 32 | 25.0 | ||
T status | T1-T2 | 6 | 21.4 | 64 | 50.4 | 0.005 |
T3-T4 | 22 | 78.6 | 63 | 49.6 | ||
N status | N0 | 6 | 21.4 | 25 | 19.7 | 0.835 |
N+ | 22 | 78.6 | 102 | 80.3 | ||
M status | M0 | 25 | 92.6 | 120 | 96.0 | 0.444 |
M+ | 2 | 7.4 | 5 | 4.0 | ||
Pathological grading | G1–2 | 14 | 66.7 | 62 | 56.4 | 0.381 |
G3 | 7 | 33.3 | 48 | 43.6 | ||
Clinical staging | I-III | 5 | 17.9 | 44 | 34.6 | 0.084 |
IV | 23 | 82.1 | 83 | 65.4 | ||
Alcohol | no/former | 3 | 11.1 | 29 | 24.2 | 0.137 |
current | 24 | 88.9 | 91 | 75.8 | ||
Tobacco | no/former | 3 | 11.1 | 29 | 23.8 | 0.147 |
current | 24 | 88.9 | 93 | 76.2 | ||
HPV | non-related1 | 24 | 88.9 | 83 | 75.5 | 0.130 |
related2 | 3 | 11.1 | 27 | 24.5 | ||